300677 Product Name: Combinatie van dapagliflozine of een farmaceutisch aanvaardbaar zout daarvan en metformine of een farmaceitisch aanvaardbaar zout daarvan, zoals beschermd door het basisoctrooi EP 1506211B1.
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 10/08/2022 | Appeal | Annex | 20 | /7/7/6/0/0/0400300677/docs/300677_14_appeal20220810022645649.pdf | ||
| 19/05/2022 | Outgoing Correspondence | Letter to applicant | 1 | /7/7/6/0/0/0400300677/docs/300677_18_481426l173.pdf | ||
| 20/04/2022 | Outgoing Correspondence | Confirmation receipt appeal | 1 | /7/7/6/0/0/0400300677/docs/300677_17_475172l072.pdf | ||
| 19/04/2022 | Appeal | Request appeal | 2 | /7/7/6/0/0/0400300677/docs/300677_15_appeal20220419125524555.pdf | ||
| 19/04/2022 | Outgoing Correspondence | Confirmation receipt appeal | 1 | /7/7/6/0/0/0400300677/docs/300677_16_474850l072.pdf | ||
| 19/04/2022 | Appeal | Subsequently filed documents appeal procedure | 2 | /7/7/6/0/0/0400300677/docs/300677_19_appeal20220420115805485.pdf | ||
| 10/03/2022 | Outgoing Correspondence | Decision refusal | 9 | /7/7/6/0/0/0400300677/docs/300677_6_464189l527a.pdf | ||
| 09/11/2021 | Incoming Correspondence Paper | Incoming Correspondence Paper | 10 | /7/7/6/0/0/0400300677/docs/300677_8_incomingcorrespondencepaper20211109020659634.pdf | ||
| 12/08/2021 | Outgoing Correspondence | Letter to applicant | 2 | /7/7/6/0/0/0400300677/docs/300677_10_428668l173.pdf | ||
| 04/10/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /7/7/6/0/0/0400300677/docs/300677_7_incomingcorrespondencepaper20161006114602744.pdf | ||
| 12/07/2016 | Outgoing Correspondence | Letter to applicant | 1 | /7/7/6/0/0/0400300677/docs/300677_13_outgoingcorrespondence20160715014104021.pdf | ||
| 04/07/2016 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /7/7/6/0/0/0400300677/docs/300677_5_incomingcorrespondencepaper20160705110608802.pdf | ||
| 05/04/2016 | Outgoing Correspondence | Letter to applicant | 2 | /7/7/6/0/0/0400300677/docs/300677_0_outgoingcorrespondence20160406025810660.pdf | ||
| 08/07/2014 | Outgoing Correspondence | Outgoing Letter | 1 | /7/7/6/0/0/0400300677/docs/300677_3_outgoingcorrespondence20140708.pdf | ||
| 07/07/2014 | SPC Documents | Annex SPC | 2 | /7/7/6/0/0/0400300677/docs/300677_1_supplprotectioncertificate20200316111521375.pdf | ||
| 07/07/2014 | SPC Documents | Annex SPC | 6 | /7/7/6/0/0/0400300677/docs/300677_2_supplprotectioncertificate20200316103200886.pdf | ||
| 07/07/2014 | Application Form | First filed application form | 3 | /7/7/6/0/0/0400300677/docs/300677_4_applicationform20140707.pdf | ||
| 07/07/2014 | SPC Documents | Marketing Authorization SPC | 3 | /7/7/6/0/0/0400300677/docs/300677_9_supplprotectioncertificate20200316103431204.pdf | ||
| 07/07/2014 | SPC Documents | Annex SPC | 47 | /7/7/6/0/0/0400300677/docs/300677_11_supplprotectioncertificate20200316111225995.pdf | ||
| 07/07/2014 | SPC Documents | Annex SPC | 28 | /7/7/6/0/0/0400300677/docs/300677_12_supplprotectioncertificate20200316111651881.pdf |